Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05272241 · ClinicalTrials.gov registry record
Registry of Asthma Characterization and Recruitment 3 (RACR3)
A clinical trial of Asthma, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- Recruiting
- Registry status
- 1,500
- Enrollment target
- 7
- Study locations
NCT05272241 is a study of Asthma that is actively recruiting participants, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 1,500 participants, roughly in line with the 1,559-participant average among 374 other Asthma trials with a reported enrollment target. The trial reports 7 study locations across 6 states.
The verdict
NCT05272241, a study of Asthma, is actively recruiting participants, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- RECRUITING
- Registry status
- 1,500 participants
- Enrollment target
- 7
- Study locations
Study Summary
This is a multi-center, non-interventional registry to create and maintain a database of participants to serve as a recruitment source for current and future DAIT NIAID-sponsored Childhood Asthma in Urban Settings (CAUSE) studies.
Conditions Studied
Study Locations (7)
New York
- Icahn School of Medicine at Mount Sinai: Division of Clinical Immunology, Immunology Institute - New York
- Columbia University Medical Center: Department of Medicine, Division of Pulmonary, Allergy and Critical Care Medicine - New York
Colorado
- Children's Hospital Colorado: Allergy Program - Aurora
District of Columbia
- Children's National Medical Center: Inner City Asthma Consortium (ICAC) Clinical Research Site - Washington D.C.
Illinois
- Ann & Robert H. Lurie Children's Hospital of Chicago: Division of Allergy and Immunology - Chicago
Massachusetts
- Boston Children's Hospital: Department of Immunology - Boston
Ohio
- Cincinnati Children's Hospital Medical Center: Asthma Center - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,500 participants |
| Start Date | 2022-04-15 |
| Est. Completion | 2028-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05272241
The ClinicalTrials.gov registry entry for NCT05272241 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,500 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 1,559-participant average among 374 other Asthma trials with a reported enrollment target. The listed sponsor is National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Asthma appearing as the primary indexed condition, and to 0 interventions.
NCT05272241 reports 7 study locations spanning 6 distinct geographic areas - top geographies include New York, Colorado, District of Columbia.
Frequently Asked Questions
What is clinical trial NCT05272241 about?
NCT05272241 is a clinical study titled "Registry of Asthma Characterization and Recruitment 3 (RACR3)". This is a multi-center, non-interventional registry to create and maintain a database of participants to serve as a recruitment source for current and future DAIT NIAID-sponsored Childhood Asthma in Urban Settings (CAUSE) studies.
What is the current status of trial NCT05272241?
This trial is currently recruiting. The enrollment target is 1,500 participants. The study started on 2022-04-15. Estimated completion is 2028-05.
What conditions does trial NCT05272241 study?
This clinical trial studies the following conditions: Asthma.
Who is sponsoring clinical trial NCT05272241?
This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05272241 being conducted?
This trial has 7 study locations across Colorado, District of Columbia, Illinois, Massachusetts, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Asthma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Innate Immunity in Allergic Asthma
RECRUITING
-
Automated Inhaler Monitoring for Asthma Medication Usage
RECRUITING · NA
-
Impact of Metabolic Dysfunction and Mucus Plugging on Asthma Physiology
RECRUITING
-
Depemokimab Asthma Imaging and Bronchoscopy Sub-Study
RECRUITING · Phase 3
-
Escitalopram in Asthma Patients With Frequent Exacerbation
RECRUITING · Phase 2
-
Measuring the Effect of Dupilumab Treatment on Mucociliary Clearance (MCC) in Subjects With Moderate to Severe Asthma
RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.